Furthermore, we reveal sets of miRNAs associated with genes frequently amplified (ERBB2) or mutated (p16INK4a, PIK3CA and/or PTEN, E-cadherin, BRCA1) in breast cancer cell lines and thus these miRNAs may contribute to the function of these oncogenes/tumor suppressors. The gene discussed is PTEN; the disease is breast cancer.